Nanoformulated Polyherbal Extract of Momordica charantia for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress
Oriental Journal Of Chemistry · 31.10.2026 · 5 (42) · 2215
DOI: 10.13005/ojc/420536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oriental Journal Of Chemistry, online erschienen am 30.10.2026. Verfasst von Piyush Chandra und 9 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While oxidative stress is a key pathophysiological mechanism underlying cardiovascular diseases (CVD), conventional cardioprotective treatments are more or less non selective and have some adverse effects, as well as being unable to restore redox balance. Momordica charantia (bitter melon) is rich in other antioxidant phytochemicals, but these are not readily available for clinical application because of the low bioavailability. The purpose of this study is to formulate and evaluate a Nanoformulated polyherbal extract (NPHE) of M. charantia along with its potential cardioprotective activity and antioxidant activity with T. arjuna, W. somnifera and O. sanctum as potential herbs. The PHE was prepared using the Soxhlet and maceration (70% ethanol) and encapsulated into PLGA nanoparticles using double emulsion-solvent evaporation method. The properties of NPHE were determined including the particle size, polydispersity index (PDI), zeta potential, morphology (TEM/SEM), encapsulation efficiency (EE%), drug loading (DL%), in vitro release, antioxidant assay (DPPH, ABTS, SOD, CAT, GPx), and cytoprotection against H9c2 cardiomyoblasts under the oxidative stress of H₂O₂ and doxorubicin (DOX). NPHE exhibited a mean diameter of 184.6 ± 9.2 nm, PDI 0.152, zeta potential −32.7 ± 3.4 mV, EE% 86.3%, and DL% 7.8%. MESMA and TEM/SEM confirmed the morphology to be spherical and non aggregated. The biphasic sustained release (76.4% after 240 h) of NPHE could be best described by Korsmeyer Peppas model (R²=0.994). Compared to unformulated PHE, NPHE demonstrated significantly lower IC₅₀ for DPPH (24.7 vs. 46.3 μg/mL) and ABTS (18.3 vs. 34.9 μg/mL), and higher SOD mimetic (42.8 vs. 28.6 U/mg), CAT (31.2 vs. 18.4 U/mg), and GPx (22.5 vs. 12.7 U/mg) activities (p
Zitieren
APA
Chandra, P., Sontakke, R., Pradhan, P., Saini, S., Naquvi, K. J., Shinde, S. A., Thokchom, S., Khopade, D. M., Sharma, R., & Bora, R. (2026). Nanoformulated Polyherbal Extract of Momordica charantia for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress. Oriental Journal Of Chemistry, 5(42), 2215. https://doi.org/10.13005/ojc/420536
Vancouver
Chandra P, Sontakke R, Pradhan P, Saini S, Naquvi KJ, Shinde SA, et al. Nanoformulated Polyherbal Extract of Momordica charantia for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress. Oriental Journal Of Chemistry. 2026;5(42):2215. doi:10.13005/ojc/420536
BibTeX
@article{Chandra2026,
author = {Chandra, Piyush and Sontakke, Rupali and Pradhan, Pankaj and Saini, Shalini and Naquvi, Kamran Javed and Shinde, Sushilkumar A. and Thokchom, Sarojbala and Khopade, Dipali M. and Sharma, Rashmi and Bora, Rinchi},
title = {Nanoformulated Polyherbal Extract of Momordica charantia for Enhanced Cardioprotective and Antioxidant Activity Against Oxidative Stress},
journal = {Oriental Journal Of Chemistry},
year = {2026},
volume = {5},
number = {42},
pages = {2215},
doi = {10.13005/ojc/420536}
}
EUVIMED